Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 23, 2012 - Issue 4
Submit an article Journal homepage
447
Views
43
CrossRef citations to date
0
Altmetric
Psoriasis

A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept

Charles W. Lynde Lynderm Research, Markham, ON, Canada
,
Aditya K. Gupta Mediprobe Research Inc., London, ON, Canada
,
Lyn Guenther The Guenther Dermatology Research Centre, London, ON, Canada
,
Yves Poulin Centre de Recherche Dermatologique du Québec Métropolitain, Québec, QC, Canada
,
Annie Levesque Innovaderm Research Inc., Montreal, QC, Canada
&
Robert Bissonnette Innovaderm Research Inc., Montreal, QC, CanadaCorrespondence[email protected]
Pages 261-267 | Received 12 May 2011, Accepted 03 Jul 2011, Published online: 10 Aug 2011

References

  • Bissonnette R. Etanercept for the treatment of psoriasis. Skin Therapy Lett. 2006;11:1–4.
  • Tan JK, Aphale A, Malaviya R, Sun Y, Gottlieb AB. Mechanisms of action of etanercept in psoriasis. J Investig Dermatol Symp Proc. 2007;12:38–45.
  • Papp KA, Tyring S, Lahfa M, Prinz J, Griffiths CE, Nakanishi AM, A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. Br J Dermatol. 2005;152:1304–1312.
  • Tyring S, Gordon KB, Poulin Y, Langley RG, Gottlieb AB, Dunn M, Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis. Arch Dermatol. 2007;143:719–726.
  • Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, Etanercept as monotherapy in patients with psoriasis. N Engl J Med. 2003;349:2014–2022.
  • Kircik L, Bagel J, Korman N, Menter A, Elmets CA, Koo J, Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes. J Drugs Dermatol. 2008;7:245–253.
  • Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol. 2010;62:114–135.
  • Mahajan R, Kaur I, Kanwar AJ Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque-type psoriasis–a randomized single-blinded placebo-controlled study. J Eur Acad Dermatol Venereol. 2010;24:595–600.
  • Wolf P, Hofer A, Legat FJ, Bretterklieber A, Weger W, Salmhofer W, Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept. Br J Dermatol. 2009;160:186–189.
  • Legat FJ, Hofer A, Wackernagel A, Salmhofer W, Quehenberger F, Kerl H, Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis. Arch Dermatol. 2007;143:1016–1022.
  • Foley P, Quirk C, Sullivan J, Dolianitis C, Hack S, Thirunavukkarasu K, Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence. J Eur Acad Dermatol Venereol. 2010;24:1135–1143.
  • Fredriksson T, Pettersson U. Severe psoriasis–oral therapy with a new retinoid. Dermatologica. 1978;157:238–244.
  • Hon-Sum Ko MDMO, Division of Dermatologic and Dental Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda MD. Clinical Design for Psoriasis. Dermatologic and Ophthalmic Drugs Advisory Committee 49th Meeting Open Session (Volume II); 1998 Mar 20; Gaithersburg MD.
  • Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)–a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–216.
  • Evers AW, Kleinpenning MM, Smits T, Boezeman J, van de Kerkhof PC, Kraaimaat FW, Treatment nonadherence and long-term effects of narrowband UV-B therapy in patients with psoriasis. Arch Dermatol. 2010;146:198–199.
  • Richards HL, Fortune DG, Griffiths CE. Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol. 2006;20:370–379.
  • Ali SM, Brodell RT, Balkrishnan R, Feldman SR. Poor adherence to treatments: a fundamental principle of dermatology. Arch Dermatol. 2007;143:912–915.
  • Sabate E Adherence to long-term therapies: evidence for action. [WWW document]: world health organization. Geneva, Switzerland; 2003 [11 November 2010]; Available from: http://apps.who.int/medicinedocs/en/d/Js4883e/1.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.